Amends the Harmonized Tariff Schedule of the United States to suspend, through December 31, 2008, the duty on formulations of Thiamethoxam, Difenoconazole, Fludioxinil and Mefenoxam which contain: Thiamethoxam Technical 3-[(2-chloro-5-thiazolyl)methyl]tetrahydro-5-methyl-N-nitro- 1,3,5-oxadiazin-4-imine), Difenoconazole Technical 1H-1,2,4-triazole, 1-[[2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl]methyl]- Fludioxinil Technical 1H-Pyrrole-3-carbonitrile, 4-(2,2-difluoro-1,3-benzodioxol-4-yl)- Mefenoxam Technical (R,S)-2-[(2,6-dimethylphenyl]-methoxyacetylamino]-propionic acid methyl ester.